Transcranial Pulse Stimulation (TPS) with the NEUROLITH® system is a new therapy option for patients with Alzheimer’s disease that allows targeted stimulation of cerebral regions.
Key-facts:
- TPS are shock waves which allow highly focal brain stimulation deep in the brain.
- TPS allows unprecedented precision for targeting brain areas.
- TPS avoids brain heating and generation of secondary stimulation maxima.
- TPS has shown to
- modulate neuronal responses (SEP data)
- stimulate neuroplastic reorganization (fMRI data)
- reduce cortical atrophy (MR cortical thickness data)
- improve brain performance in AD
- recent clinical observations indicate motor improvements in Parkinson’s* - TPS has been proven to be safe in more than 2,500 human applications.
*The clinical study for the treatment of Parkinson's patients with the NEUROLITH® system directed by Prof. Dr Roland Beisteiner, started September 2020 at MedUni Vienna.